Therapeutic Advances in Gastroenterology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.8 | Q2 | 70.6% | 1.123 | Q1 | 86.7% |
| 2024 | 3.4 | Q2 | 68.7% | 1.370 | Q1 | 90.8% |
| 2023 | 3.9 | Q1 | 79.1% | 1.189 | Q1 | 89.1% |
| 2022 | 4.2 | Q2 | 77.6% | 1.226 | Q1 | 90.3% |
| 2021 | 4.8 | Q2 | 73.5% | 1.191 | Q1 | 89.8% |
| 2020 | — | — | 1.278 | Q1 | 90.0% | |
| 2019 | — | — | 1.290 | Q1 | 90.4% | |
| 2018 | — | — | 1.553 | Q1 | 92.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1756-2848
ISSN
1756-283X
region
Western Europe
coverage
2008-2026